STAT3 and neoplasm: Similar combinatorial methods are consistent with our results on the synergistic impact of Concanavalin A and Silibinin, both of which not only display cytotoxic and pro-apoptotic activities, but additionally inhibit STAT3 signaling, a critical modulator of immune suppression and tumor progression.